EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 142 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $418 | -93.3% | 48,012 | -84.0% | 0.00% | -100.0% |
| Q1 2024 | $6,195 | +67.9% | 299,687 | +87.7% | 0.00% | +100.0% |
| Q4 2023 | $3,690 | +911.0% | 159,642 | +249.6% | 0.00% | – |
| Q3 2023 | $365 | +87.2% | 45,659 | +103.4% | 0.00% | – |
| Q2 2023 | $195 | +137.8% | 22,451 | -19.7% | 0.00% | – |
| Q1 2023 | $82 | +228.0% | 27,974 | +299.3% | 0.00% | – |
| Q4 2022 | $25 | -99.7% | 7,005 | +533.4% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 1,106 | -15.5% | 0.00% | – |
| Q2 2022 | $10,000 | -79.6% | 1,309 | -67.6% | 0.00% | – |
| Q1 2022 | $49,000 | – | 4,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,551,521 | $13,498,233 | 4.40% |
| Cormorant Asset Management, LP | 8,325,000 | $72,427,500 | 4.18% |
| ORACLE INVESTMENT MANAGEMENT INC | 231,857 | $2,017,156 | 1.88% |
| Finepoint Capital LP | 707,404 | $6,154,415 | 1.75% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,175,823 | $45,029,660 | 1.65% |
| Octagon Capital Advisors LP | 1,093,503 | $9,513,476 | 1.50% |
| TCG Crossover Management, LLC | 922,335 | $8,024,315 | 0.84% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 37,838 | $329,191 | 0.42% |
| Corton Capital Inc. | 49,905 | $434,174 | 0.23% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $870,000 | 0.20% |